Genprex, Inc.
NASDAQ Capital MarketTotal Valuation
Genprex, Inc. carries a market capitalization of 1.17M, placing it among publicly traded companies globally.
| Market Cap | 1.17M |
| Enterprise Value | N/A |
Share Statistics
Genprex, Inc. currently has 9.04M shares outstanding.
| Shares Outstanding | 9.04M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.12 |
| P/TBV Ratio | 1.26 |
| P/FCF Ratio | -1.49 |
| P/OCF Ratio | -1.49 |
Financial Position
Genprex, Inc. maintains a current ratio of 5.61, meaning it holds 5.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 5.61 |
| Quick Ratio | 5.38 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -21.68 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -127.12 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Genprex, Inc.'s stock has declined approximately -94.97627% over the past 52 weeks. The 50-day moving average sits at 1.12, while the 200-day moving average is 4.53.
| Beta (5Y) | N/A |
| 52-Week Price Change | -94.97627% |
| 50-Day Moving Average | 1.12 |
| 200-Day Moving Average | 4.53 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -16.04M, while operating income came in at -16.04M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -16.04M |
| Pretax Income | -16.73M |
| Net Income | -16.73M |
| EBITDA | -16.04M |
| EBIT | -16.04M |
| Earnings Per Share (EPS) | -1.42 |
Balance Sheet
Total book value stands at -175.48M, with working capital of 15.45M providing operational flexibility.
| Cash & Cash Equivalents | 18.05M |
| Total Debt | N/A |
| Net Debt | -18.05M |
| Equity (Book Value) | -175.48M |
| Book Value Per Share | -14.91 |
| Working Capital | 15.45M |
Cash Flow
Genprex, Inc. produced -14.29M in operating cash flow over the past twelve months.
| Operating Cash Flow | -14.29M |
| Capital Expenditures | N/A |
| Free Cash Flow | -14.29M |
| FCF Per Share | -1.21 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -135.53 |
| FCF Yield | -67.08 |
Stock Splits
Genprex, Inc.'s most recent stock split took place on October 21, 2025 with a 50:1 split ratio.
| Last Split Date | 10/21/2025 |
| Split Ratio | 50:1 |
Scores
Genprex, Inc. posts an Altman Z-Score of -10.01, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -10.01 |